Graft loss including death · solid organ transplant recipients
It is very uncertain whether extended changes graft loss (including death with functioning graft) Time frame: 30… compared with short duration antibiotics (very low certainty).
1 finding from 1 review
UTI · solid organ transplant recipients
It is very uncertain whether extended changes other infection: UTI Time frame: 30 days compared with short duration antibiotics (very low certainty).
1 finding from 1 review
Other infection: septicaemia Time frame: 2 to 6 weeks · solid organ transplant recipients
It is very uncertain whether extended changes other infection: septicaemia Time frame: 30 days compared with short duration antibiotics (very low certainty).
1 finding from 1 review
Other infection: pneumonia Time frame: 30 days · solid organ transplant recipients
It is very uncertain whether extended changes other infection: pneumonia Time frame: 30 days compared with short duration antibiotics (very low certainty).
1 finding from 1 review
Adverse drug reactions · solid organ transplant recipients
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Surgical site infection · solid organ transplant recipients
It is very uncertain whether extended changes surgical site infections* (all) Time frame: 30 days compared with short duration antibiotics (very low certainty).
1 finding from 1 review
Surgical site infections: kidney transplant recipients Time frame: 30 days · solid organ transplant recipients
It is very uncertain whether extended changes surgical site infections: kidney transplant recipients Time frame:… compared with short duration antibiotics (very low certainty).
1 finding from 1 review
Persistent bacteriuria · children with acute pyelonephritis
Agent: Third generation cephalosporin showed no clear difference in persistent bacteriuria compared with other antibiotic (low certainty).
1 finding from 1 review
Recurrent UTI after end of therapy · children with acute pyelonephritis
Agent: Third generation cephalosporin showed no clear difference in recurrent UTI after end of therapy compared with other antibiotic (low certainty).
1 finding from 1 review
Persistent symptoms · children with acute pyelonephritis
Agent: Third generation cephalosporin may leads to lower persistent symptoms after end of treatment compared with other antibiotic (low certainty).
1 finding from 1 review
Persistent bacteriuria · children with lower urinary tract infection
It is very uncertain whether single‐dose changes persistent bacteriuria compared with short‐course (3‐7 days) antibiotics (very low certainty).
1 finding from 1 review
Recurrence · children with lower urinary tract infection
It is very uncertain whether single‐dose changes recurrence compared with short‐course (3‐7 days) antibiotics (very low certainty).
1 finding from 1 review
Re‐infection · children with lower urinary tract infection
It is very uncertain whether single‐dose changes re‐infection compared with short‐course (3‐7 days) antibiotics (very low certainty).
1 finding from 1 review
Persistent bacteriuria · children with lower urinary tract infection
It is very uncertain whether single‐dose changes persistent bacteriuria compared with conventional 10‐day antibiotic treatment (very low certainty).
1 finding from 1 review
Persistent symptoms · children with lower urinary tract infection
It is very uncertain whether single‐dose changes persistent symptoms compared with conventional 10‐day antibiotic treatment (very low certainty).
1 finding from 1 review
Persistent bacteriuria and symptoms · children with lower urinary tract infection
It is very uncertain whether single‐dose changes persistent bacteriuria and symptoms compared with conventional 10‐day antibiotic treatment (very low certainty).
1 finding from 1 review
Recurrence · children with lower urinary tract infection
It is very uncertain whether single‐dose changes recurrence compared with conventional 10‐day antibiotic treatment (very low certainty).
1 finding from 1 review
Repeat positive urine culture · primary VUR
It is very uncertain whether endoscopic injection treatment changes repeat positive urine culture by 1 year compared with antibiotics alone (very low certainty).
1 finding from 1 review
Microbial resistance to prophylactic drug · primary VUR
It is very uncertain whether endoscopic injection treatment changes microbial resistance to the prophylactic drug compared with antibiotics alone (very low certainty).
1 finding from 1 review
Number of participants with symptomatic UTI · primary VUR
Probiotics showed no clear difference in all symptomatic UTI by 1 year compared with antibiotic prophylaxis (low certainty).
1 finding from 1 review